Benefits of liraglutide treatment in overweight and obese older individuals with prediabetes.

Kim, Sun H; Abbasi, Fahim; Lamendola, Cindy; Liu, Alice; Ariel, Danit; Schaaf, Patricia; Grove, Kaylene; Tomasso, Vanessa; Ochoa, Hector; Liu, Yeheng V; Chen, Yii-Der Ida; Reaven, Gerald

Kim, Sun H; Abbasi, Fahim; Lamendola, Cindy; Liu, Alice; Ariel, Danit; Schaaf, Patricia; Grove, Kaylene; Tomasso, Vanessa; Ochoa, Hector; Liu, Yeheng V; Chen, Yii-Der Ida; Reaven, Gerald.

Affiliation

Kim SH; Corresponding author: Sun H. Kim, sunhkim@stanford.edu.

Diabetes Care ; 36(10): 3276-82, 2013 Oct.

Article in En | MEDLINE | ID: mdl-23835684

Subject(s)

Glucagon-Like Peptide 1/analogs & derivatives; Hypoglycemic Agents/therapeutic use; Obesity/drug therapy; Prediabetic State/drug therapy; Body Weight/drug effects; Caloric Restriction; Diabetes Mellitus, Type 2/blood; Diabetes Mellitus, Type 2/drug therapy; Double-Blind Method; Female; Glucagon-Like Peptide 1/therapeutic use; Humans; Insulin Resistance/physiology; Liraglutide; Male; Middle Aged; Obesity/blood; Overweight/blood; Overweight/drug therapy; Prediabetic State/blood; Triglycerides/blood; Weight Loss/drug effects

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Prediabetic State / Glucagon-Like Peptide 1 / Hypoglycemic Agents / Obesity Type of study: Clinical_trials / Risk_factors_studies Limits: Female / Humans / Male / Middle aged Language: En Journal: Diabetes Care Year: 2013 Type: Article

Fulltext

XML

PubMed Links

Search on Google